The cancer diagnostics market is estimated to be valued at US$ 59.1 Billion in 2022 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Cancer diagnostics involves detection of biological markers present in tissues, blood or other body fluids that are indicative of cancer. Some of...
0 Commentarios
0 Acciones
1787 Views
0 Vista previa